Research at MOMA - Overview

 

Translational Research

Translational research at MOMA  integrates clinical specimens and clinical studies with in vitro studies and molecular models of colon, bladder and prostate cancer diseases. MOMA is manifesting its international position by conducting translational research at a competitive level.

Comprehensive tissue banks including detailed clinical follow-up are established and maintained by MOMA in close cooperation with clinicians treating cancer patients.

 

Research Aims

Molecular classification of patients in relation to disease stage, prognosis, outcome and treatment and insight into molecular pathways in subgroups of patients are desired.
Bioinformatic modelling and large databases help to understand the importance of our molecular findings.
 

Modern technology

MOMA uses advanced techniques and equipment for investigating gene expression, genomic instability, genomic variation, several RNA species and laser microdissected tissues, and for functional classification of early molecular changes and pathways.

MOMA has modern laboratory facilities and computer equipment. See a list of equipment

 

 

Current Research Centers and Large Projects

NOCRC (2014-2018)

Precision medicine for clinically localised prostate cancer, The Danish Cancer Society (2014-2017)

Improved Molecular Diagnostics for Prostate Cancer, The Danish National Advanved Technology Foundation (2013-2017)

SYSCOL - EU FP7 project "Systems Biology of Colorectal Cancer" (2011-2015)

MOLPROS - "Molecular Prediction of Prostate Cancer Risk and Aggressiveness" (MPRAS), The Danish Council for Strategic Research (2011-2014)

Uromol - EU FP7 project "Prediction of bladder cancer disease course using risk scores that combine molecular and clinical risk factors" (2008-2013)

CETAME - The Lundbeck Foundation Center for Translational Medicine (2008-2013)

CMCC - Center for Molecular Clinical Cancer Research, A John and Birthe Meyer Cancer Center (2005-2014)